BIOPHARMACEUTICAL STUDIES ON HYDANTOIN DERIVATIVES. V.^<1)> PHARMACOKINETICS AND PHARMACODYNAMICS OF 5,5-DIPHENYLHYDANTOIN AND 1-BENZENESULFONYL-5,5-DIPHENYLHYDANTOIN

概要

論文の詳細を見る
Disposition of 1-benzenesulfonyl-5,5-diphenylhydantoin (II) having a potent anti-inflammatory activity was compared with that of 5,5-diphenylhydantoin (I), an antiepileptic drug, in order to elucidate whether the pharmacodynamic difference between them can be explained by their physicochemical and pharmacokinetic properties. After oral administration of I-^<14>C to rats, radioactivity was distributed in all tissues including the brain, whereas after II-^<14>C administration, the concentrations of radioactivity in most tissues were lower than those in plasma. The results were consistent with the finding obtained by whole-body autoradiography which revealed that after oral administration of II-^<14>C to rats, radioactivity was not transferred into brain but was significantly transferred into inflamed tissues. Brain/plasma concentration ratio of I was about 1.3,whereas that of II was about 0.05. Plasma protein binding of I having pK_a value of 8.30 was about 88%, whereas that of II having pK_a value of 4.89 was about 99%. The changes in physicochemical properties due to introduction of a benzenesulfonyl group into the hydantoin ring may be responsible for the difference in the disposition between I and II. When II was cerebroventricularly administered to mice, it showed a potent anticonvulsant activity against maximal electroshock seizure, the activity being comparable to that for I. This indicates that the earlier failure to demonstrate the activity of II in a routine screening test for antiepileptic drugs was due to the inability of II to penetrate the bloodbrain barrier and to achieve effective concentration in the brain. II was found to inhibit the biosynthesis of prostaglandin. These findings along with the physicochemical properties suggest that although II does not fall structurally under any category of anti-inflammatory drugs the mechanism of action may be similar to that for non-steroidal acidic anti-inflammatory drugs.
公益社団法人日本薬学会の論文

BIOPHARMACEUTICAL STUDIES ON HYDANTOIN DERIVATIVES. V.^<1)> PHARMACOKINETICS AND PHARMACODYNAMICS OF 5,5-DIPHENYLHYDANTOIN AND 1-BENZENESULFONYL-5,5-DIPHENYLHYDANTOIN

スポンサーリンク

概要

著者

関連論文

スポンサーリンク